Brain metastasis and response to ado-trastuzumab emtansine: a case report and literature review

Clin Breast Cancer. 2015 Apr;15(2):e163-6. doi: 10.1016/j.clbc.2014.10.003. Epub 2014 Oct 19.

Authors

Richa Kalsi¹, Steven Feigenberg², Young Kwok², Katherine Tkaczuk¹, Minesh Mehta², Saranya Chumsri³

Affiliations

¹ Department of Medicine, University of Maryland School of Medicine, The Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD.
² Department of Radiation Oncology, University of Maryland School of Medicine, The Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD.
³ Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL. Electronic address: [email protected].

PMID: 25454740
DOI: 10.1016/j.clbc.2014.10.003

No abstract available

Keywords: Ado-trastuzumab emtansine; CNS metastasis; HER2; Lapatinib; Radiation.

Publication types

Case Reports
Research Support, Non-U.S. Gov't
Review

MeSH terms

Ado-Trastuzumab Emtansine
Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Antineoplastic Agents / therapeutic use*
Brain Neoplasms / drug therapy*
Brain Neoplasms / secondary*
Female
Humans
Inflammatory Breast Neoplasms / pathology*
Maytansine / analogs & derivatives*
Maytansine / therapeutic use
Salvage Therapy / methods
Trastuzumab

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Maytansine
Trastuzumab
Ado-Trastuzumab Emtansine